OCUL
Ocular Therapeutix, Inc. · Healthcare
Chief Medical Officer Nadia Waheed sold $27K of Ocular Therapeutix, Inc.
Sold$27,167
$7.74Price
3,510Shares
−1%Stake
What OCUL did after the filing
- The stock from Tue, Feb 24 close, $8.96
- −6.0%
- S&P 500, same days
- −1.6%
Measured over 30 trading days, to the Apr 8 close.
Traded Fri, Feb 20. Filed Tue, Feb 24, 1:13 PM ET, during the session. Returns use the Feb 24 close and the Apr 8 close. Not investment advice.